<DOC>
	<DOCNO>NCT00805597</DOCNO>
	<brief_summary>The purpose study evaluate postmastectomy radiotherapy breast cancer patient one three positive node .</brief_summary>
	<brief_title>Clinical Trial Postmastectomy Radiotherapy Breast Cancer With One Three Positive Nodes</brief_title>
	<detailed_description>Eligible breast cancer patient mastectomy axillary dissection randomize 2 group : radiotherapy 50 Gy 25 fraction within 5 week ipsilateral chest wall supraclavicular nodal region , radiotherapy . During radiotherapy , patient follow efficacy toxicity radiotherapy evaluate .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Ipsilateral histologically confirm invasive breast cancer Undergone total mastectomy axillary dissection T12 one three axillary lymph node positive A minimum 10 axillary node dissect Fit chemotherapy ( indicate ) , endocrine therapy ( indicate ) postoperative irradiation Written , inform consent Patients undergone previous irradiation ipsilateral chest wall supraclavicular region Previous concurrent malignant nonmelanomatous skin cancer Unable unwilling give inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>mastectomy</keyword>
	<keyword>one three positive node</keyword>
	<keyword>radiotherapy</keyword>
</DOC>